The AHA submitted comments to the Centers for Medicare & Medicaid Services June 1 on the inpatient psychiatric facility prospective payment system proposed rule for fiscal year 2027. The AHA expressed concerns that CMS’ proposed market basket update is inadequate and urged CMS to revisit the proposal and work with Congress to reduce the high productivity adjustment; in addition, the AHA suggested that CMS delay the proposed cap on outlier payments pending further analysis of the drivers of high-cost stays. In other comments, the AHA recommended that CMS delay its proposed implementation of the IPF patient assessment instrument. The AHA said that in its current form, the IPF-PAI would result in an enormous burden and costs for psychiatric providers with minimal value to patient care. The AHA encouraged the agency to continue using existing IPF quality reporting requirements in the meantime while developing a different instrument. 

Headline
The AHA provided comments June 9 to the Centers for Medicare & Medicaid Services on its proposed Comprehensive Care for Joint Replacement Expanded…
Headline
Eli Lilly said June 1 it will deny 340B Drug Pricing Program discounts to providers that do not meet its documentation requirements by next week.In a statement…
Headline
The AHA commented June 1 on the Centers for Medicare & Medicaid Services’ skilled nursing facility prospective payment system proposed rule for fiscal year…
Headline
The AHA June 1 urged the Centers for Medicare & Medicaid Services to revisit its market basket forecast and work with Congress to reduce the productivity…
Headline
The 4th U.S. Circuit Court of AppealsMay 28 agreed to rehear challenges to 340B contract pharmacy laws from West Virginia and Maryland. In April, a three-judge…
Headline
The Wall Street Journal today published a letter to the editor from AHA General Counsel Chad Golder responding to a May 7 editorial criticizing the 340B Drug…